Why Sorrento Therapeutics Stock Bumped Higher Today
A majority-owned subsidiary reports very good clinical trial results for a leading pipeline drug.
Source: fool.com
Stay updated with breaking news from Breakthrough Designation Status. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A majority-owned subsidiary reports very good clinical trial results for a leading pipeline drug.
Scilex Holding Company, a commercial-stage, non-opioid biopharmaceutical pain management company, announces highly significant positive top-line results...